293 related articles for article (PubMed ID: 17502342)
41. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6).
Wong CC; Botting NP; Orfila C; Al-Maharik N; Williamson G
Biochem Pharmacol; 2011 Apr; 81(7):942-9. PubMed ID: 21244849
[TBL] [Abstract][Full Text] [Related]
42. The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin.
Windass AS; Lowes S; Wang Y; Brown CD
J Pharmacol Exp Ther; 2007 Sep; 322(3):1221-7. PubMed ID: 17585018
[TBL] [Abstract][Full Text] [Related]
43. Transport of aminopterin by human organic anion transporters hOAT1 and hOAT3: Comparison with methotrexate.
Uwai Y; Iwamoto K
Drug Metab Pharmacokinet; 2010; 25(2):163-9. PubMed ID: 20460822
[TBL] [Abstract][Full Text] [Related]
44. Interaction of cysteine conjugates with human and rabbit organic anion transporter 1.
Groves CE; Muñoz L; Bahn A; Burckhardt G; Wright SH
J Pharmacol Exp Ther; 2003 Feb; 304(2):560-6. PubMed ID: 12538807
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the interaction between nonsteroidal anti-inflammatory drugs and methotrexate using human organic anion transporter 3-transfected cells.
Maeda A; Tsuruoka S; Kanai Y; Endou H; Saito K; Miyamoto E; Fujimura A
Eur J Pharmacol; 2008 Oct; 596(1-3):166-72. PubMed ID: 18789319
[TBL] [Abstract][Full Text] [Related]
46. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.
Kimura H; Takeda M; Narikawa S; Enomoto A; Ichida K; Endou H
J Pharmacol Exp Ther; 2002 Apr; 301(1):293-8. PubMed ID: 11907186
[TBL] [Abstract][Full Text] [Related]
47. Transport of organic anions across the basolateral membrane of proximal tubule cells.
Burckhardt BC; Burckhardt G
Rev Physiol Biochem Pharmacol; 2003; 146():95-158. PubMed ID: 12605306
[TBL] [Abstract][Full Text] [Related]
48. The renal-specific transporter mediates facilitative transport of organic anions at the brush border membrane of mouse renal tubules.
Imaoka T; Kusuhara H; Adachi-Akahane S; Hasegawa M; Morita N; Endou H; Sugiyama Y
J Am Soc Nephrol; 2004 Aug; 15(8):2012-22. PubMed ID: 15284287
[TBL] [Abstract][Full Text] [Related]
49. Regulation of Expression of Renal Organic Anion Transporters OAT1 and OAT3 in a Model of Ischemia/Reperfusion Injury.
Preising C; Schneider R; Bucher M; Gekle M; Sauvant C
Cell Physiol Biochem; 2015; 37(1):1-13. PubMed ID: 26277839
[TBL] [Abstract][Full Text] [Related]
50. Transport of xanthurenic acid by rat/human organic anion transporters OAT1 and OAT3.
Uwai Y; Honjo E
Biosci Biotechnol Biochem; 2013; 77(7):1517-21. PubMed ID: 23832370
[TBL] [Abstract][Full Text] [Related]
51. Methotrexate-loxoprofen interaction: involvement of human organic anion transporters hOAT1 and hOAT3.
Uwai Y; Taniguchi R; Motohashi H; Saito H; Okuda M; Inui K
Drug Metab Pharmacokinet; 2004 Oct; 19(5):369-74. PubMed ID: 15548848
[TBL] [Abstract][Full Text] [Related]
52. Involvement of rat and human organic anion transporter 3 in the renal tubular secretion of topotecan [(S)-9-dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride].
Matsumoto S; Yoshida K; Ishiguro N; Maeda T; Tamai I
J Pharmacol Exp Ther; 2007 Sep; 322(3):1246-52. PubMed ID: 17556638
[TBL] [Abstract][Full Text] [Related]
53. Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule.
Zhang X; Groves CE; Bahn A; Barendt WM; Prado MD; Rödiger M; Chatsudthipong V; Burckhardt G; Wright SH
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F999-1010. PubMed ID: 15251863
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory effect of caffeic acid on human organic anion transporters hOAT1 and hOAT3: a novel candidate for food-drug interaction.
Uwai Y; Ozeki Y; Isaka T; Honjo H; Iwamoto K
Drug Metab Pharmacokinet; 2011; 26(5):486-93. PubMed ID: 21697612
[TBL] [Abstract][Full Text] [Related]
55. Interaction between rhein acyl glucuronide and methotrexate based on human organic anion transporters.
Yuan Y; Yang H; Kong L; Li Y; Li P; Zhang H; Ruan J
Chem Biol Interact; 2017 Nov; 277():79-84. PubMed ID: 28890383
[TBL] [Abstract][Full Text] [Related]
56. Characterization of the renal tubular transport of zonampanel, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, by human organic anion transporters.
Hashimoto T; Narikawa S; Huang XL; Minematsu T; Usui T; Kamimura H; Endou H
Drug Metab Dispos; 2004 Oct; 32(10):1096-102. PubMed ID: 15377641
[TBL] [Abstract][Full Text] [Related]
57. Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites.
Alebouyeh M; Takeda M; Onozato ML; Tojo A; Noshiro R; Hasannejad H; Inatomi J; Narikawa S; Huang XL; Khamdang S; Anzai N; Endou H
J Pharmacol Sci; 2003 Dec; 93(4):430-6. PubMed ID: 14737013
[TBL] [Abstract][Full Text] [Related]
58. The anthraquinone drug rhein potently interferes with organic anion transporter-mediated renal elimination.
Wang L; Pan X; Sweet DH
Biochem Pharmacol; 2013 Oct; 86(7):991-6. PubMed ID: 23973525
[TBL] [Abstract][Full Text] [Related]
59. A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters.
Tahara H; Kusuhara H; Endou H; Koepsell H; Imaoka T; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2005 Oct; 315(1):337-45. PubMed ID: 16006492
[TBL] [Abstract][Full Text] [Related]
60. Expression studies and functional characterization of renal human organic anion transporter 1 isoforms.
Bahn A; Ebbinghaus C; Ebbinghaus D; Ponimaskin EG; Fuzesï L; Burckhardt G; Hagos Y
Drug Metab Dispos; 2004 Apr; 32(4):424-30. PubMed ID: 15039295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
